COAG
Hemab Therapeutics Holdings, Inc.
39.33
+0.56 (+1.44%)
52w low 23.00
55.42 high
50.4% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|
| Operating Cash Flow | -13.03M | -15.33M | -21.58M | -22.64M | |
| Depreciation & Amort | 75.00K | 77.00K | 73.00K | 75.00K | |
| Capital Expenditure | -16.00K | -- | -112.00K | -23.00K | |
| Free Cash Flow | -13.05M | -15.33M | -21.70M | -22.66M | |
| Investing Cash Flow | -5.99M | 21.50M | -15.85M | -107.44M | |
| Financing Cash Flow | -29.00K | -30.00K | -460.00K | 317.58M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--